Archives: Case Studies

Outsourcing Pharmacovigilence

Client Challenge

A global pharmaceutical and medical device company faced challenges in scaling its workforce to meet the demands of rapid business growth and increasing regulatory oversight. Specifically, the company struggled to secure incremental staffing resources with the specialized expertise required for critical functions such as pharmacovigilance (PV), device vigilance (DV), complaint management (CM), and medical information (MI). Local resource shortages made it difficult to maintain compliance and operational efficiency across these high-impact areas.

RCA Approach

To address its resource challenges, the company partnered with Regulatory Compliance Associates® Inc. (RCA) to design and implement a cost-effective, scalable outsourcing model. This strategic solution was developed to accommodate current operational needs while remaining flexible for future changes in staffing and regulatory requirements. The approach centered on the following key elements:

  • Strategic Resource Allocation: Lower-cost outsourced staff were engaged to manage repetitive, high-volume, low-complexity tasks, enabling internal high-value resources to concentrate on complex, high-risk activities with greater patient impact.
  • Call Center Outsourcing: RCA helped transition call center operations for pharmacovigilance (PV), device vigilance (DV), complaint management (CM), and medical information (MI) to external providers, ensuring effective stakeholder engagement—including medical professionals, sales representatives, and consumers.
  • Data Management Support: Internal information management systems were supplemented with outsourced data entry, quality monitoring, and case surveillance services to improve accuracy and throughput.
  • Global Partner Identification: A Business Process Outsourcing Partner (BPOP) with a large global footprint was selected to provide offshore and outsourced call center capabilities, improving efficiency and reducing operational costs.
  • End-to-End Process Support: Outsourced PV, DV, and CM functions included contact management, intake, triage, logistics, and categorization/prioritization of potential high-risk events (e.g., adverse events, product malfunctions) for escalation and regulatory reporting.
  • Medical Information (MI) Support: Frontline customer service functions—such as call handling, case logging, and the delivery of verbal and written medical information—were successfully transitioned to outsourced resources.
  • Retention of Critical Control: Throughout the process, the company maintained control over all critical decisions, including report ability assessments, product safety determinations, regulatory strategy, and risk management

Results

The business challenge was effectively resolved through the implementation of an outsourced and off-shored contact center model. This strategic shift yielded measurable improvements and long-term benefits across operational, financial, and regulatory areas. Key outcomes included:

  • Significant Cost Savings: The new model led to a reduction in annual operational expenses by $1.3 million, representing a 16%savings on a functional annual spend of $8.0 million.
  • Process Efficiency Gains: By leveraging the core competencies of the outsourcing partner, the company achieved key performance improvements that were unattainable with internal resources alone. Notably, the complaint registration cycle time was reduced from five days to same-day processing.
  • Strategic Resource Allocation: High-cost internal resources were redirected to focus on critical decision-making activities by offloading repetitive, high-volume tasks.
  • Established Strategic Growth Partner: The outsourcing partner became a reliable resource during business expansion, regulatory responses, recalls, and acquisitions—providing scalable support aligned with evolving business needs.
  • Centralized Operations: The shift from a decentralized structure to a centralized contact center enabled streamlined operations, improved process oversight, and resource optimization at the regional level.
  • Customer-Centric Flexibility: The model supported adaptation to evolving customer communication preferences (e.g., transitioning from phone to email-based intake).
  • Enhanced Data Quality Oversight: With added quality surveillance processes in place, the company improved data integrity and content accuracy—capabilities that were previously unsustainable with internal staffing.
  • Leadership Enablement: Functional leadership was freed to focus on process design, Voice of Customer initiatives, and critical regulatory strategy, rather than day-to-day transactional execution.
  • Strengthened Regulatory Standing: The functional organization emerged as a strong point in regulatory audits by maintaining a clear focus on compliance, managing variability, and demonstrating continuous process improvement.
  • Built-in Redundancy: The outsourced model provided built-in crisis resilience, including redundancy and backup operations during disruptions such as severe weather or system outages.

The outsourced and off-shored contact center model was recognized as a major success within the organization. It enabled access to high-caliber medical professionals, established a scalable and strategic partnership for future growth, and delivered substantial operational cost reductions. The implementation process was benchmarked as a best-in-class approach and now serves as a model for other functional areas within the company.

Compliance Assurance Leads to Passed FDA Inspection

Background

Qualitest, a leading developer and manufacturer of affordable, high-quality generic pharmaceuticals, wanted to be prepared for upcoming FDA inspections.

RCA Approach

Qualitest engaged Regulatory Compliance Associates® Inc. (RCA) to prepare the company in advance of an FDA Audit. RCA reviewed over 170 investigations relating to Qualitest operations to suggest improvements and identify areas of risk. By working efficiently and by tapping into scheduled downtime, RCA was able to complete the project in three months.

“RCA not only remediated our warning letter, but they also improved our workforce efficiency and preparedness for agency audits. We didn’t realize what it took to be prepared for an inspection. Prior to RCA, we had cursory reviews by auditors and inspectors, but we always suspected there were issues that weren’t identified. We experienced a thorough inspection when RCA came. Our systems were closely examined by RCA’s mock inspectors, to the point where we really felt like we had been through a real inspection. They identified many deficiencies and areas for process improvement. We now know we are in good shape and are getting better by practicing what we learned. RCA provided great value to us.”

Result

Qualitest implemented the recommended changes, including company-wide training, and received no observations during the next FDA inspection.

Manufacturing Automation for Medical Devices

Background

A medical device manufacturer developed custom automation equipment to assemble and weld medical-grade check valves, incorporating a PLC, HMI, vision system, and ultrasonic welder. During an ISO audit, it was discovered that the software controlling the automated assembly equipment had not been validated. Compounding the issue, newly built equipment—critical to meeting urgent production demands—also required validation, but the client lacked the necessary in-house software validation expertise.

Regulatory Compliance Associates® Inc. (RCA) was engaged to develop comprehensive validation documentation and deliver expert validation services. RCA ensured the software met regulatory requirements and that the valve assembly system was fully validated and ready for production—all within an aggressive timeline.

RCA Approach

RCA integrated software validation as a core component of the overall equipment validation process. Following GAMP 5 guidelines, a risk assessment was conducted to identify user and functional requirements that posed the highest risk to product quality and patient safety. These high-risk functions were subjected to the most rigorous testing to ensure the automation equipment consistently assembled components in compliance with critical product specifications. This risk-based approach not only ensured a robust and compliant validation but also significantly reduced the overall project timeline.

Result

The validation was successfully completed within the aggressive timeline, with efforts strategically focused on equipment functions that posed the highest risk to product quality and patient safety. As a result, the client received a dependable, risk-based validation, and the new equipment was ready for production by the project’s target date.

Creating Operational Discipline to Support Quality Initiatives

Background

A global health care company received an FDA Warning Letter for quality issues with its manufacturing facility. As the organization began working through the issues identified in the Warning Letter, it became clear, even with good quality systems, improved operational execution was needed to sustain successful results. The operational improvements were focused in areas such as shop floor discipline / execution, facility housekeeping and maintenance, managerial focus on all levels and, most of all, assessing and attacking specific operational shortfalls within all the operational groups.

RCA helped the organization recognize data quality gaps, develop action plans, and create tracking mechanisms to monitor operational progress of the Quality initiatives. RCA raised the bar on operational discipline and feedback.

RCA Approach

The manufacturing facility engaged Regulatory Compliance Associates® Inc. (RCA) to develop and implement a plan for operational improvements to support the evolving quality management system. This assessment and subsequent improvements involved needed support from the somewhat skeptical operations management group. RCA and the local operations management team worked jointly to assess the plant and identify gap areas needing improvement to support the quality initiatives.

RCA assisted the facility to develop and implement a tracking system to monitor operational tasks, ongoing process improvements and ways to enforce accountability of key personnel. This tracking included key performance metrics for the following areas: training compliance, floor audit performance, batch record error improvement, document timeliness and line clearance performance. Recognizing that the operations management team was inexperienced, RCA engaged and mentored the key operations floor managers as they began implementing improvements and tracking progress.

Result

Besides crafting and implementing the operations improvement plan, RCA assisted the company to instill a culture of operational excellence and individual accountability with an inexperienced team. RCA helped the organization recognize gaps, develop action plans and create a tracking mechanism to monitor operational progress. Not only did these actions clearly improve quality and compliance, but they provided financial returns such as a deviation and inspection cost reductions as well as increased available line time which more than covered the cost of RCA’s third party support. Most importantly, the management team learned the importance of communication across all departments and at all levels to achieve success. Ultimately, the facility’s commitment will contribute to an environment of sustainability long after the RCA consultants have left.

 

 

Process Validation Remediation

Client Challenge

A large global medical device manufacturer received a Warning Letter from the FDA due to recurring 483 observations related to process validation deficiencies. The company was required to remediate validations for over 500 products and establish a sustainable, risk-based validation program in advance of upcoming FDA inspections.

The remediation effort needed to take place without interrupting ongoing manufacturing operations. Additionally, extensive training was necessary to build internal capabilities and ensure long-term compliance. Foundational gaps—including missing or incomplete design and process risk analyses, as well as inadequate test method validations (TMVs)—had to be resolved before initiating process validations. Further complicating the effort, software validation studies were needed for automated manufacturing systems and electronic data collection platforms.

RCA Approach

Regulatory Compliance Associates® Inc. (RCA) designed and implemented a risk-prioritized remediation plan that aligned with both regulatory expectations and business continuity needs. The approach began with a comprehensive assessment of existing design and validation documentation across the product portfolio. RCA then developed robust risk analysis documents for each major product line, forming the foundation for a sustainable validation strategy.

In collaboration with stakeholders from 14 global manufacturing sites, RCA established a validation program that balanced compliance requirements with ongoing production demands. Customized training programs were developed and deployed to ensure internal teams could sustain the improvements long term. To expedite execution and maintain consistency, RCA deployed experienced validation teams to each site, working alongside local staff to perform the necessary validations efficiently and in full regulatory alignment.

Result

Over the course of the 18-month engagement, RCA delivered 24 updated risk management files and completed more than 1,800 unique Installation Qualification (IQ), Operational Qualification (OQ), Performance Qualification (PQ), and test method validation studies. RCA’s comprehensive training approach—combining classroom instruction with hands-on guidance—ensured that teams across all global sites were equipped to maintain compliance independently. Subsequent FDA inspections at client facilities resulted in no additional 483 observations related to validation, affirming the effectiveness and sustainability of the remediation effort.

Product Cleaning Endotoxin Control

Background

A medical device manufacturer was encountering recurring instances of unacceptable endotoxin levels on finished, cleaned surgical needles. The issue led to an FDA 483 observation citing non conformances with established procedures related to needle cleaning and endotoxin control. Regulatory Compliance Associates® Inc. (RCA) was engaged to conduct a comprehensive analysis of the needle cleaning process, develop a protocol to evaluate cleaning efficacy, and recommend improvements to both the process and the associated specifications.

RCA Approach

RCA designed and executed controlled testing using a “worst-case” product scenario, inoculating surgical needles with approximately 300 EU/device. The objective was to achieve post-cleaning endotoxin levels below 2.15 EU/device. Testing revealed a gradual accumulation of bio-burden in the cleaning water across sequential batches, highlighting the need for process improvements. RCA supported the client in designing and building a new, automated cleaning system, which included clean compressed air and vacuum drying capabilities. The new equipment and cleaning process were fully validated. To further strengthen contamination control, RCA developed a clean-room behavior SOP and conducted comprehensive staff training. Additionally, a robust sampling plan was implemented, incorporating defined action and alert levels for endotoxin monitoring on finished product.

Result

As a result of the improvements, product endotoxin levels were substantially reduced, and the risk of nonconforming product reaching customers was effectively mitigated. These outcomes were supported and documented through rigorous process validation and enhanced process controls, ensuring compliance with regulatory expectations and strengthening overall product quality.